Back to trial detailsIntake questionnaire
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Applying to Fox Chase Cancer Center · Philadelphia, Pennsylvania
Answer a few short questions to share with the research team.
0 of 4 answered